NFKB1 and melanoma: Indicaxanthin has been demonstrated to inhibit IκBα degradation in melanoma A375 cells at 100 μM, a concentration at which it impairs NF-κB signaling and inhibits 50% cell proliferation (IC50) (Allegra et al., 2018).